Background <p>Bile acids (BAs) play critical roles in regulating glucose, lipid and energy metabolism, but its effects on type 2 diabetes is not very clear, we studied the effects of ursodeoxycholic acid (UDCA) intervention on blood glucose and related metabolic indexes in type 2 diabetes rats.</p> Methods <p>Male SD rats (<i>n</i> = 30) were divided into three groups: the normal control group (Group A, <i>n</i> = 10), the type 2 diabetes group (Group B, <i>n</i> = 10), and the type 2 diabetes plus UDCA intervention group (Group C, <i>n</i> = 10). At the end of experiment, oral glucose tolerance tests (OGTTs) were performed. Serum biochemical parameters, the levels of insulin and C-peptide, liver triglyceride (TG) and total cholesterol (TC) levels were determined. The expression of genes related to lipid, glucose and BAs metabolism in the liver was examined by real-time PCR.</p> Results <p>Compared with those in Group A, in Group B, the areas under the curves (AUC) for the OGTTs increased, while the AUC for levels of insulin and C-peptide decreased, the levels of the liver TG and TC, liver enzymes and serum TG and TC increased. Compared with those in Group B, in Group C, all of the above indicators improved. The expression of genes related to lipid, glucose and BAs metabolism in the liver changed.</p> Conclusions <p>UDCA decreased glucose levels and alleviated related metabolic abnormalities in type 2 diabetes rats.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Effects of ursodeoxycholic acid on blood glucose and related metabolic indexes in type 2 diabetes rats

  • Xiu-Ping Bai,
  • Ling-Yan Wei,
  • Yu-Feng Han,
  • Xiao-Jin Han,
  • Feng Dong

摘要

Background

Bile acids (BAs) play critical roles in regulating glucose, lipid and energy metabolism, but its effects on type 2 diabetes is not very clear, we studied the effects of ursodeoxycholic acid (UDCA) intervention on blood glucose and related metabolic indexes in type 2 diabetes rats.

Methods

Male SD rats (n = 30) were divided into three groups: the normal control group (Group A, n = 10), the type 2 diabetes group (Group B, n = 10), and the type 2 diabetes plus UDCA intervention group (Group C, n = 10). At the end of experiment, oral glucose tolerance tests (OGTTs) were performed. Serum biochemical parameters, the levels of insulin and C-peptide, liver triglyceride (TG) and total cholesterol (TC) levels were determined. The expression of genes related to lipid, glucose and BAs metabolism in the liver was examined by real-time PCR.

Results

Compared with those in Group A, in Group B, the areas under the curves (AUC) for the OGTTs increased, while the AUC for levels of insulin and C-peptide decreased, the levels of the liver TG and TC, liver enzymes and serum TG and TC increased. Compared with those in Group B, in Group C, all of the above indicators improved. The expression of genes related to lipid, glucose and BAs metabolism in the liver changed.

Conclusions

UDCA decreased glucose levels and alleviated related metabolic abnormalities in type 2 diabetes rats.